Turk J Hematol. 2026; 43(1): 91-92 | DOI: 10.4274/tjh.galenos.2025.2025.0252
Long-Term Response to Single-Agent Lenalidomide in an Elderly Patient with Relapsed Hepatosplenic T-Cell Lymphoma
Süreyya Yiğit Kaya1, Rima Akil1, Gülşah Akyol2, Amir Hossein Abedi3, Serhat Çelik4, Leylagül Kaynar11İstanbul Medipol University, Faculty of Medicine, Department of Hematology, İstanbul, Türkiye
2Erciyes University, Faculty of Medicine, Department of Hematology, Kayseri, Türkiye
3İstanbul Medipol University, Faculty of Medicine, Department of Internal Medicine, İstanbul, Türkiye
4Yıldırım Beyazıt University, Yenimahalle Training and Research Hospital, Department of Hematology, Ankara, Türkiye
Keywords: Hepatosplenic T-cell lymphoma, Lenalidomide, Peripheral T-cell lymphoma, Elderly patient
Nüks Hepatosplenik T-Hücreli Lenfomalı Yaşlı Bir Hastada Tek Ajan Lenalidomide Uzun Dönem Yanıt
Süreyya Yiğit Kaya1, Rima Akil1, Gülşah Akyol2, Amir Hossein Abedi3, Serhat Çelik4, Leylagül Kaynar11İstanbul Medipol University, Faculty of Medicine, Department of Hematology, İstanbul, Türkiye
2Erciyes University, Faculty of Medicine, Department of Hematology, Kayseri, Türkiye
3İstanbul Medipol University, Faculty of Medicine, Department of Internal Medicine, İstanbul, Türkiye
4Yıldırım Beyazıt University, Yenimahalle Training and Research Hospital, Department of Hematology, Ankara, Türkiye
Anahtar Kelimeler: Hepatosplenik T-hücreli lenfoma, Lenalidomid, Periferik T-hücreli lenfoma, Yaşlı hasta
Corresponding Author: Süreyya Yiğit Kaya
Manuscript Language: English